Cannara Biotech Inc. Reports Fourth Quarter and Fiscal Year 2021 Results
Ryan Allway December 8th, 2021 Fiscal 2021 revenues of $17.3 million, gross profit of $10.5 million or 61% and an Adjusted EBITDA of $1.5 million, strong indicators of Cannara’s performance and successful operating strategy All financial results are reported in Canadian dollars, unless otherwise stated. MONTREAL, Dec. 8, 2021 /CNW/ – Cannara Biotech Inc. (“Cannara” or the... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )